| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Acute Liver Failure | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Liver Failure | |||||
| Liver Failure, Acute | |||||
| 3 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| Hepatic Insufficiency | |||||
| Liver Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| acetylcysteine | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| N-monoacetylcystine | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Antidotes | |||||
| Antioxidants | |||||
| Antiviral Agents | |||||
| Expectorants | |||||
| Free Radical Scavengers | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Respiratory System Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| University of Texas | |||||
|
